A Novel Bio-Psychosocial-Behavioral Treatment Model of Panic Disorder
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Seon-Cheol | - |
dc.contributor.author | Kim, Yong-Ku | - |
dc.date.accessioned | 2021-09-01T21:52:27Z | - |
dc.date.available | 2021-09-01T21:52:27Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2019-01 | - |
dc.identifier.issn | 1738-3684 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/68428 | - |
dc.description.abstract | To conceptualize a novel bio-psychosocial-behavioral treatment model of panic disorder (PD), it is necessary to completely integrate behavioral, psychophysiological, neurobiological, and genetic data. Molecular genetic research on PD is specifically focused on neurotransmitters, including serotonin, neuropeptides, glucocorticoids, and neurotrophins. Although pharmacological interventions for PD are currently available, the need for more effective, faster-acting, and more tolerable pharmacological interventions is unmet. Thus, glutamatergic receptor modulators, orexin receptor antagonists, corticotrophin-releasing factor 1 receptor antagonists, and other novel mechanism-based anti-panic therapeutics have been proposed. Research on the neural correlates of PD is focused on the dysfunctional "cross-talk" between emotional drive (limbic structure) and cognitive inhibition (prefrontal cortex) and the fear circuit, which includes the amygdala-hippocampus-prefrontal axis. The neural perspective regarding PD supports the idea that cognitive-behavioral therapy normalizes alterations in top-down cognitive processing, including increased threat expectancy and attention to threat. Consistent with the concept of "personalized medicine," it is speculated that Research Domain Criteria can enlighten further treatments targeting dysfunctions underlying PD more precisely and provide us with better definitions of moderators used to identify subgroups according to different responses to treatment. Structuring of the "negative valence systems" domain, which includes fear/anxiety, is required to define PD. Therefore, targeting glutamate-and orexin-related molecular mechanisms associated with the fear circuit, which includes the amygdala-hippocampus-prefrontal cortex axis, is required to define a novel bio-psychosocial-behavioral treatment model of PD. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | KOREAN NEUROPSYCHIATRIC ASSOC | - |
dc.subject | RANDOMIZED CONTROLLED-TRIAL | - |
dc.subject | TEMPORAL-LOBE VOLUME | - |
dc.subject | CEREBRAL-BLOOD-FLOW | - |
dc.subject | NEUROANATOMICAL HYPOTHESIS | - |
dc.subject | RECEPTOR AGONIST | - |
dc.subject | BIOPSYCHOSOCIAL MODEL | - |
dc.subject | ORBITOFRONTAL CORTEX | - |
dc.subject | FEAR EXTINCTION | - |
dc.subject | ANIMAL-MODELS | - |
dc.subject | FACIAL AFFECT | - |
dc.title | A Novel Bio-Psychosocial-Behavioral Treatment Model of Panic Disorder | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Yong-Ku | - |
dc.identifier.doi | 10.30773/pi.2018.08.21.1 | - |
dc.identifier.scopusid | 2-s2.0-85065741569 | - |
dc.identifier.wosid | 000456663600002 | - |
dc.identifier.bibliographicCitation | PSYCHIATRY INVESTIGATION, v.16, no.1, pp.4 - 15 | - |
dc.relation.isPartOf | PSYCHIATRY INVESTIGATION | - |
dc.citation.title | PSYCHIATRY INVESTIGATION | - |
dc.citation.volume | 16 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 4 | - |
dc.citation.endPage | 15 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | ssci | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Psychiatry | - |
dc.relation.journalWebOfScienceCategory | Psychiatry | - |
dc.subject.keywordPlus | RANDOMIZED CONTROLLED-TRIAL | - |
dc.subject.keywordPlus | TEMPORAL-LOBE VOLUME | - |
dc.subject.keywordPlus | CEREBRAL-BLOOD-FLOW | - |
dc.subject.keywordPlus | NEUROANATOMICAL HYPOTHESIS | - |
dc.subject.keywordPlus | RECEPTOR AGONIST | - |
dc.subject.keywordPlus | BIOPSYCHOSOCIAL MODEL | - |
dc.subject.keywordPlus | ORBITOFRONTAL CORTEX | - |
dc.subject.keywordPlus | FEAR EXTINCTION | - |
dc.subject.keywordPlus | ANIMAL-MODELS | - |
dc.subject.keywordPlus | FACIAL AFFECT | - |
dc.subject.keywordAuthor | Bio-psychosocial-behavioral | - |
dc.subject.keywordAuthor | Cognitive-behavioral therapy | - |
dc.subject.keywordAuthor | Fear circuit | - |
dc.subject.keywordAuthor | Research Domain Criteria | - |
dc.subject.keywordAuthor | Panic disorder | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.